-The Times of India NEW DELHI: The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops. Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a...
More »SEARCH RESULT
Total Matching Records found : 781
Executive's Environmental Dilemmas: Unpacking a Committee’s Report -Manju Menon and Kanchi Kohli
-Economic and Political Weekly The High-Level Committee set up by the Narendra Modi government to review the major laws relating to environment protection has, in its recommendations, worked towards two sets of objectives: one, to separate business from the messiness of governance, and, two, to redraw the line of demarcation between the judiciary and the executive. Manju Menon (manjumenon@namati.org) and Kanchi Kohli (kanchikohli@namati.org) are with the Centre for Policy Research - Namati...
More »Rethinking IP think tank -Latha Jishnu
-Down to Earth Government sidelines its committee of experts to set up new panel to review India's intellectual property rights policy The politics of protecting intellectual property rights (IPR) is becoming more curiouswith the commerce ministry setting up a think tank to draft a national IPR policy while sidelining a committee of experts it had set up earlier. Annoyed academics who were asked to help formulate the policy in July this year...
More »Overdependence on China for drug ingredients worries NSA -Sushmi Dey
-The Times of India NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt. According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature. "The national security adviser had highlighted concerns related...
More »Centre sits on royalty slabs for bio resources, loses Rs 25,000 cr a year -Jay Mazoomdaar
-The Indian Express It took the National Biodiversity Authority (NBA) six years, 18 drafts and a prod from the National Green Tribunal (NGT) to finalise the Guidelines for Access and Benefit Sharing (ABS) this August. Three months on, it is yet to notify the rules that would allow it to collect from domestic and foreign companies 0.1-1 per cent of their ex-factory gross sales of products using biological resources and traditional...
More »
